125 related articles for article (PubMed ID: 26107473)
21. Postoperative posterior segment complications in eyes treated with the Boston type I keratoprosthesis.
Goldman DR; Hubschman JP; Aldave AJ; Chiang A; Huang JS; Bourges JL; Schwartz SD
Retina; 2013 Mar; 33(3):532-41. PubMed ID: 23073339
[TBL] [Abstract][Full Text] [Related]
22. Boston type 1 keratoprosthesis for failed keratoplasty.
Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
[TBL] [Abstract][Full Text] [Related]
23. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
24. Outcomes with the Boston Type 1 Keratoprosthesis at Instituto de Microcirugía Ocular IMO.
Güell JL; Arcos E; Gris O; Aristizabal D; Pacheco M; Sanchez CL; Manero F
Saudi J Ophthalmol; 2011 Jul; 25(3):281-4. PubMed ID: 23960937
[TBL] [Abstract][Full Text] [Related]
25. Keratoprosthesis surgery for end-stage corneal blindness in asian eyes.
Tan DT; Tay AB; Theng JT; Lye KW; Parthasarathy A; Por YM; Chan LL; Liu C
Ophthalmology; 2008 Mar; 115(3):503-510.e3. PubMed ID: 18319104
[TBL] [Abstract][Full Text] [Related]
26. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
Palioura S; Kim B; Dohlman CH; Chodosh J
Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
[TBL] [Abstract][Full Text] [Related]
27. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
28. Boston type 1 keratoprosthesis: the New York Eye and Ear experience.
Patel AP; Wu EI; Ritterband DC; Seedor JA
Eye (Lond); 2012 Mar; 26(3):418-25. PubMed ID: 22173079
[TBL] [Abstract][Full Text] [Related]
29. Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion.
Abou Shousha M; Eleiwa T; Gibbons A; Smith C; Edelstein S; Kontadakis G; Schmitz Z; Abernathy J; Chod R; Bodnar Z; McDaniel K; Bentivegna R; Akduman L
J Ophthalmol; 2019; 2019():9648614. PubMed ID: 31467698
[TBL] [Abstract][Full Text] [Related]
30. Boston type 1 keratoprosthesis: the CHUM experience.
Robert MC; Harissi-Dagher M
Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
[TBL] [Abstract][Full Text] [Related]
31. Results with the Boston Type I keratoprosthesis after Acanthamoeba keratitis.
Santos A; Silva LD; de Sousa LB; de Freitas D; de Oliveira LA
Am J Ophthalmol Case Rep; 2017 Jun; 6():71-73. PubMed ID: 29260063
[TBL] [Abstract][Full Text] [Related]
32. Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review.
Shanbhag SS; Saeed HN; Paschalis EI; Chodosh J
Ocul Surf; 2018 Jul; 16(3):272-281. PubMed ID: 29597010
[TBL] [Abstract][Full Text] [Related]
33. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
Wagoner MD; Welder JD; Goins KM; Greiner MA
Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
[TBL] [Abstract][Full Text] [Related]
34. Boston keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy.
Brown CR; Wagoner MD; Welder JD; Cohen AW; Goins KM; Greiner MA; Kitzmann AS
Cornea; 2014 Aug; 33(8):801-5. PubMed ID: 24932767
[TBL] [Abstract][Full Text] [Related]
35. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
[TBL] [Abstract][Full Text] [Related]
36. VITREORETINAL COMPLICATIONS IN EYES WITH BOSTON KERATOPROSTHESIS TYPE I.
Rishi P; Rishi E; Koundanya VV; Mathur G; Iyer G; Srinivasan B
Retina; 2016 Mar; 36(3):603-10. PubMed ID: 26398693
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
[TBL] [Abstract][Full Text] [Related]
38. Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis.
Prabhasawat P; Chotikavanich S; Ngowyutagon P; Pinitpuwadol W
Am J Ophthalmol; 2021 Dec; 232():40-48. PubMed ID: 34102154
[TBL] [Abstract][Full Text] [Related]
39. Glaucoma Evaluation and Management in Eyes With Boston Type 1 and Aurolab Keratoprostheses in an Indian Cohort.
Senthil S; Mohamed A; Shanbhag SS; Durgam SS; Bagga B; Sangwan VS; Basu S
Cornea; 2022 May; 41(5):552-561. PubMed ID: 35383615
[TBL] [Abstract][Full Text] [Related]
40. Challenges in management of the Boston Keratoprosthesis Type 1.
Koo EH; Hannush SB
Curr Opin Ophthalmol; 2021 Jul; 32(4):385-388. PubMed ID: 33973907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
